Javier J. Rodriguez
Net Worth

Last updated:

What is Javier J. Rodriguez net worth?

The estimated net worth of Mr. Javier J. Rodriguez is at least $284,585,812 as of 16 Sep 2024. He owns shares worth $114,615,828 as insider, has earned $81,049,984 from insider trading and has received compensation worth at least $88,920,000 in DaVita Inc..

What is the salary of Javier J. Rodriguez?

Mr. Javier J. Rodriguez salary is $4,940,000 per year as Chief Executive Officer & Executive Director in DaVita Inc..

How old is Javier J. Rodriguez?

Mr. Javier J. Rodriguez is 54 years old, born in 1971.

What stocks does Javier J. Rodriguez currently own?

As insider, Mr. Javier J. Rodriguez owns shares in one company:

Company Title Shares Price per share Total value
DaVita Inc. (DVA) Chief Executive Officer & Executive Director 837,835 $136.8 $114,615,828

What does DaVita Inc. do?

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Javier J. Rodriguez insider trading

DaVita Inc.

Mr. Javier J. Rodriguez has made 33 insider trades between 2007-2024, according to the Form 4 filled with the SEC. Most recently he sold 50,000 units of DVA stock worth $8,252,500 on 16 Sep 2024.

The largest trade he's ever made was exercising 750,000 units of DVA stock on 6 Mar 2024. As of 16 Sep 2024 he still owns at least 837,835 units of DVA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 50,000 $165.05 $8,252,500
Sale
Common Stock 9,881 $162.85 $1,609,121
Sale
Common Stock 7,943 $155.94 $1,238,592
Sale
Common Stock 32,176 $155.93 $5,017,300
Option
Common Stock 750,000 $67.8 $50,850,000
Option
Stock Appreciation Rights 750,000 $67.8 $50,850,000
Option
Stock Appreciation Rights 750,000 $67.8 $50,850,000
Option
Common Stock 750,000 $67.8 $50,850,000
Option
Stock Appreciation Rights 50,000 $67.8 $3,390,000
Option
Common Stock 50,000 $67.8 $3,390,000
Sale
Common Stock 7,397 $126.87 $938,465
Option
Common Stock 450,000 $67.8 $30,510,000
Sale
Common Stock 67,603 $126.11 $8,525,144
Option
Stock Appreciation Rights 450,000 $67.8 $30,510,000
Option
Stock Appreciation Rights 500,000 $67.8 $33,900,000
Option
Common Stock 500,000 $67.8 $33,900,000
Option
Common Stock 88,213 $66.29 $5,847,640
Sale
Common Stock 1,400 $100.04 $140,062
Sale
Common Stock 15,516 $99.38 $1,542,027
Option
Stock Appreciation Rights 88,213 $66.29 $5,847,640
Option
Common Stock 79,909 $65.48 $5,232,441
Option
Stock Appreciation Rights 79,909 $65.48 $5,232,441
Option
Stock Appreciation Rights 124,091 $75.42 $9,358,943
Sale
Common Stock 27,053 $122.23 $3,306,553
Option
Common Stock 124,091 $75.42 $9,358,943
Option
Common Stock 560,000 $58.94 $33,006,400
Option
Common Stock 280,000 $58.94 $16,503,200
Option
Stock Appreciation Rights 112,500 $55.34 $6,225,750
Option
Common Stock 112,500 $55.34 $6,225,750
Sale
Common Stock 22,532 $67.48 $1,520,459
Sale
Common Stock 1,294 $66.21 $85,671
Option
Stock Appreciation Rights 80,000 $36.96 $2,956,800
Option
Common Stock 80,000 $36.96 $2,956,800
Sale
Common Stock 36,466 $75.44 $2,751,104
Option
Stock Appreciation Rights 216,667 $43.35 $9,392,514
Sale
Common Stock 89,912 $73.51 $6,609,071
Option
Common Stock 216,667 $43.35 $9,392,514
Sale
Common Stock 36,466 $81.5 $2,972,015
Sale
Common Stock 20,946 $84.57 $1,771,403
Option
Common Stock 43,333 $43.35 $1,878,486
Option
Stock Appreciation Rights 43,333 $43.35 $1,878,486
Sale
Common Stock 2,803 $79.4 $222,558
Option
Stock Appreciation Rights 4,667 $31.7 $147,944
Option
Common Stock 4,667 $31.7 $147,944
Sale
Common Stock 7,000 $67.5 $472,500
Option
Stock Appreciation Right 51,333 $31.7 $1,627,256
Sale
Common Stock 27,663 $68.4 $1,892,011
Option
Common Stock 51,333 $31.7 $1,627,256
Option
Common Stock 130,000 $22.86 $2,971,800
Option
Stock Appreciation Right 130,000 $22.86 $2,971,800
Sale
Common Stock 85,210 $65.77 $5,604,176
Sale
Common Stock 3,500 $129.99 $454,955
Option
Stock Appreciation Right 140,000 $117.88 $16,503,200
Option
Common Stock 46,665 $50.37 $2,350,516
Sale
Common Stock 24,695 $109 $2,691,829
Option
Stock Appreciation Right 46,665 $50.37 $2,350,516
Sale
Common Stock 28,323 $107.05 $3,031,949
Option
Common Stock 53,335 $50.37 $2,686,484
Option
Stock Appreciation Right 53,335 $50.37 $2,686,484
Sale
Common Stock 19,162 $97.73 $1,872,721
Sale
Common Stock 1,111 $97.78 $108,635
Sale
Common Stock 70,054 $96.52 $6,761,472
Option
Stock Appreciation Right 150,000 $54.13 $8,119,500
Option
Common Stock 150,000 $54.13 $8,119,500
Option
Stock Appreciation Right 7,500 $52.12 $390,900
Option
Common Stock 32,500 $52.12 $1,693,900
Option
Common Stock 127,500 $52.12 $6,645,300
Sale
Common Stock 20,910 $85.58 $1,789,373
Option
Stock Appreciation Right 127,500 $52.12 $6,645,300
Sale
Common Stock 24,983 $71.5 $1,786,359
Option
Common Stock 150,000 $49.7 $7,455,000
Sale
Common Stock 49,311 $74.05 $3,651,282
Option
Stock Appreciation Right 150,000 $49.7 $7,455,000
Option
Stock Appreciation Right 50,000 $49.7 $2,485,000
Option
Common Stock 50,000 $49.7 $2,485,000
Sale
Common Stock 11,286 $63.6 $717,790
Option
Common Stock 46,000 $54.75 $2,518,500
Sale
Common Stock 24,000 $46 $1,104,000
Option
Stock Options (Right to Buy) 24,000 $46 $1,104,000
Option
Common Stock 20,000 $31.04 $620,800
Sale
Common Stock 20,000 $31.04 $620,800
Option
Stock Options (Right to Buy) 20,000 $31.04 $620,800
Option
Common Stock 40,000 $29.53 $1,181,000
Option
Stock Options (Right to Buy) 40,000 $29.53 $1,181,000
Sale
Common Stock 12,750 $13.73 $175,096
Option
Stock Options (Right to Buy) 12,750 $13.73 $175,096
Option
Common Stock 12,750 $13.73 $175,096
Option
Common Stock 30,000 $28.01 $840,300
Option
Stock Options (Right to Buy) 30,000 $28.01 $840,300
Sale
Common Stock 30,000 $60.43 $1,812,990

DaVita key executives

DaVita Inc. executives and other stock owners filed with the SEC: